Sort By:
Relevance
Published
Display per page:
10
20
30
50
Intercellular transfer of SerpinE2 activates PI3K-AKT and β-catenin signaling to promote cardiac hypertrophy
Lifang Lv, Xiao Liu, Xiaona Wang, Huizhen Zhang, Mingxiu Zhang, Chao Li, Yao Liu, Lan Zheng, Ruonan Yang, Guozhao Wei, Lina Xuan, Qiang Gao, Xiaoqiang E, Tong Yu, Tianyu Li, Hongli Shan, Xuelian Li
2025, 5(3): 180-192. doi: 10.1515/fzm-2025-0021
Keywords: cold exposure, serpinE2, cardiac hypertrophy, cellular communication, endocytosis
  Background  Effective inhibition of pathological cardiac hypertrophy is critical for managing various cardiovascular diseases, especially in cold environments. The communication between cardiomyocytes and fibroblasts, mediated by secreted proteins, plays a significant role in the development and progression of pathological cardiac hypertrophy. Serpin Family E Member 2 (serpinE2), secreted by fibroblasts into the extracellular space, has been implicated in this process. However, whether serpinE2 can be internalized by cardiomyocytes and whether cold exposure influences this process remains unclear.  Materials and methods  Mice were subjected to cold exposure (4 ℃, 12 h/day for 8 weeks), and cardiac hypertrophy was induced by transverse aortic constriction (TAC). SerpinE2 expression was silenced by short interfering RNA (siRNA). Cardiac fibroblasts were stimulated with angiotensin Ⅱ (Ang Ⅱ) to induce serpinE2 secretion. Exogenous recombinant serpinE2, labeled with DyLight 488 or His-tag, was used to evaluate its internalization and functional role in cardiomyocytes. Internalization was inhibited by using antibodies against serpinE2, heparin, or endocytosis inhibitors (β-cyclodextrin, nystatin, dynasore, and chlorpromazine). Chromatin immunoprecipitation followed by quantitative polymerase chain reaction (PCR) was used to assess the binding of the transcription factor CDX1 to the serpinE2 promoter.  Results  Cold exposure significantly increased serpinE2 mRNA and protein expression in mouse hearts. SerpinE2 levels were also upregulated in plasma and cardiac tissue following TAC. Knockdown of serpinE2 attenuated TAC-induced hypertrophy, restored left ventricular function, and reduced atrial natriuretic peptide, brain natriuretic peptide, and β-myosin heavy chain fragment levels. Exogenous serpinE2 promoted cardiomyocyte hypertrophy, an effect that was reversed by serpinE2 knockdown. Co-culture with conditioned medium from Ang Ⅱ-stimulated fibroblasts increased serpinE2 expression in cardiomyocytes. Exogenous serpinE2 was internalized via endocytosis, which was inhibited by antibodies, heparin, and endocytosis blockers. Internalized serpinE2 activated the protein kinase B (AKT)/β-catenin pathway in cardiomyocytes. CDX1 bound to the serpinE2 promoter and promoted its transcription in fibroblasts. CDX1 overexpression increased serpinE2 and collagen expression, while its suppression had the opposite effect. Administration of exogenous fibroblast growth factor 4 (FGF4) or overexpression of FGF4 plasmid upregulated CDX1, serpinE2, and collagen expression in fibroblasts.  Conclusions  SerpinE2 expression is responsive to cold stress and mediates intercellular communication between fibroblasts and cardiomyocytes. Fibroblast-secreted serpinE2 is internalized by cardiomyocytes via endocytosis, promoting hypertrophy through activation of the phosphatidylinositol 3-kinase (PI3K)-AKT/β-catenin pathway. The FGF4-CDX1 axis regulates serpinE2 expression and secretion in cardiac fibroblasts.
YBX1 inhibits mitochondrial-mediated apoptosis in ischemic heart through the PI3K/AKT signaling pathway
Fangfang Bi, Miao Cao, Yuquan Wang, Qingming Pan, Zehong Jing, Danyang Bing, Lifang Lyu, Tong Yu, Tianyu Li, Xuelian Li, Haihai Liang, Hongli Shan, Yuhong Zhou
2024, 4(1): 51-64. doi: 10.2478/fzm-2024-0006
Keywords: YBX1, PI3K/AKT, apoptosis, mitochondrial function, myocardial infarction
  Background  Myocardial infarction (MI) is associated with higher morbidity and mortality in the world, especially in cold weather. YBX1 is an RNA-binding protein that is required for pathological growth of cardiomyocyte by regulating cell growth and protein synthesis. But YBX1, as an individual RNA-binding protein, regulates cardiomyocytes through signaling cascades during myocardial infarction remain largely unexplored.  Methods  In vivo, the mouse MI model was induced by ligating the left anterior descending coronary artery (LAD), and randomly divided into sham operation group, MI group, MI+ YBX1 knockdown/overexpression group and MI+ negative control (NC) group. The protective effect of YBX1 was verified by echocardiography and triphenyltetrazolium chloride staining. In vitro, mitochondrial-dependent apoptosis was investigated by using CCK8, TUNEL staining, reactive oxygen species (ROS) staining and JC-1 staining in hypoxic neonatal mouse cardiomyocytes (NMCMs).  Results  YBX1 expression of cardiomyocytes was downregulated in a mouse model and a cellular model on the ischemic condition. Compared to mice induced by MI, YBX1 overexpression mediated by adeno-associated virus serotype 9 (AAV9) vector reduced the infarcted size and improved cardiac function. Knockdown of endogenous YBX1 by shRNA partially aggravated ischemia-induced cardiac dysfunction. In hypoxic cardiomyocytes, YBX1 overexpression decreased lactic dehydrogenase (LDH) release, increased cell viability, and inhibited apoptosis by affecting the expression of apoptosis related proteins, while knockdown of endogenous YBX1 by siRNA had the opposite effect. Overexpression of YBX1 restored mitochondrial dysfunction in hypoxic NMCMs by increasing mitochondrial membrane potential and ATP content and decreasing ROS. In hypoxic NMCMs, YBX1 overexpression increased the expression of phosphorylated phosphatidylinositol 3 kinase (PI3K)/AKT, and the antiapoptosis effect of YBX1 was eliminated t by LY294002, PI3K/AKT inhibitor.  Conclusion  YBX1 protected the heart from ischemic damage by inhibiting the mitochondrial-dependent apoptosis through PI3K/AKT pathway. It is anticipated that YBX1 may serve as a novel therapeutic target for MI.
Notum protects against myocardial infarction-induced heart dysfunction by alleviating cardiac fibrosis
Tongzhu Jin, Zhen Ye, Ruonan Fang, Yue Li, Wei Su, Qianqian Wang, Tianyu Li, Hongli Shan, Yanjie Lu, Haihai Liang
2024, 4(1): 41-50. doi: 10.2478/fzm-2024-0005
Keywords: cardiac fibrosis, Notum, Wnt/β-catenin, senescence, myocardial infarction
  Background and Objective  Cardiac fibrosis is a pathological reparative process that follows myocardial infarctionand is associated with compromised cardiac systolic and reduced cardiac compliance. The Wnt signaling pathway is closely implicated in organ fibrosis, and Notum, a highly conserved secreted inhibitor, modulates Wnt signaling. The objective of this study was to explore the role and mechanism of Notum in cardiac fibrosis.  Methods  A mouse model of cardiac remodeling was established through left coronary artery ligation surgery, with the addition of Notum injection following myocardial infarction surgery. The protective effect of Notum on myocardial infarction was assessed by evaluating cardiac function, including survival rate, echocardiographic assessment, and cardiac contraction analyses. Inflammatory cell necrosis and infiltration were confirmed through H & E and Masson staining. The expression of fibrosis-related genes and β-catenin pathway markers was detected using Western blot quantificational RT-PCR (qRT-PCR). Additionally, EdU, wound healing, and immunofluorescence staining analyses were performed to detect the effect of Notum's in transforming growth factor beta-1 (TGF-β1) induced myofibroblast transformation.  Results  The administration of Notum treatment resulted in enhanced survival rates, improved cardiac function, and decreased necrosis and infiltration of inflammatory cells in mice subjected to left coronary artery ligation. Furthermore, Notum effectively impeded the senescence of cardiac fibroblasts and hindered their pathological transformation into cardiac fibroblasts. Additionally, it significantly reduced collagen production and attenuated the activation of the Wnt/β-catenin pathway. Our preliminary investigations successfully demonstrated the therapeutic potential of Notum in both fibroblasts in vitro and in a mouse model of myocardial infarction-induced cardiac fibrosis in vivo.  Conclusion  Notum inhibition of the Wnt/β-catenin signaling pathway and cardiac fibroblast senescence ultimately hampers the onset of cardiac fibrosis. Our findings suggest that Notum could represent a new therapeutic strategy for the treatment of cardiac fibrosis.